Search - tctmd.com

Displaying 261 - 280 of 8219

Sort: Relevancy | Date

News Industry News TCT 2016

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

November 01, 2016

News Industry News

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

November 01, 2016

News Conference News TCT 2016

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

Bayesian Statistics: Utility and Interpretation

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Marc Etienne Jolicoeur

November 01, 2016

Presentation TCT 2016

Propensity-Matched Analysis: Advantages and Pitfalls

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Tracy Y. Wang

November 01, 2016

Presentation TCT 2016

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Somjot S. Brar

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Presenter: Ted Feldman, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Subgroup Analyses: How Useful or Harmful Are They?

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Sanjay Kaul

November 01, 2016

Presentation TCT 2016

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert

November 01, 2016

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

Presentation TCT 2016

Treatment of a Rare Complication in the 21st Century

Presenter: Wojtek Wojakowski, Balint Kittka

October 31, 2016

Presentation TCT 2016

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Presenter: Neil E. Moat, John G. Webb, Marina Urena

October 31, 2016

Presentation TCT 2016

Metallic DES in STEMI: Are There Experimental or Clinical Differences Between Devices?

Presenter: Deepak L. Bhatt, Stefan K. James, Tullio Palmerini

October 31, 2016

Presentation TCT 2016

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

Presenter: Emerson C. Perin, Bernard J. Gersh

October 31, 2016

Presentation TCT 2016

Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors Clinical, Anatomic, Technique-related, and Device-specific

Presenter: Neil E. Moat, John G. Webb, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

What Are the Right Endpoints for CLI Clinical Trials?

Presenter: George L Adams, John F Angle, Patrick J. Geraghty

October 31, 2016

Presentation TCT 2016

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

Presenter: Emerson C. Perin, Mariann Gyöngyösi

October 31, 2016

Presentation TCT 2016

M-Dock: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Maurice Buchbinder

October 31, 2016

Presentation TCT 2016

Caisson: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Mathew Williams

October 31, 2016

Advertisement

Dedicated Stent Study Conducted in Women and Minority Assesses Risks of Adverse Cardiovascular Events Following Coronary Stent Procedures

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Bayesian Statistics: Utility and Interpretation

Propensity-Matched Analysis: Advantages and Pitfalls

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Subgroup Analyses: How Useful or Harmful Are They?

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Treatment of a Rare Complication in the 21st Century

Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR

Metallic DES in STEMI: Are There Experimental or Clinical Differences Between Devices?

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors Clinical, Anatomic, Technique-related, and Device-specific

What Are the Right Endpoints for CLI Clinical Trials?

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

M-Dock: Design and Clinical Trial Updates

Caisson: Design and Clinical Trial Updates

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content